This article is more than 5 years old. Information may no longer be current.
FDA approves Light Adjustable Lens from RxSight
Click Here to Manage Email Alerts
The FDA has approved the Light Adjustable Lens and Light Delivery Device from RxSight, according to an FDA press release.
This is the first medical device system that can make adjustments to the lens power after cataract surgery to correct refractive errors.
The IOL is made of a material that will react to UV light, which the Light Delivery Device provides, at 17 to 21 days after surgery, according to the release. Patients will have three to four light treatments over 1 to 2 weeks, depending on the amount of adjustment needed.
“Until now, refractive errors that are common following cataract surgery could only be corrected with glasses, contact lenses or refractive surgery,” Malvina Eydelman, MD, director of the Division of Ophthalmic, and Ear, Nose and Throat at the FDA’s Center for Devices and Radiological Health, said in the release. “This system provides a new option for certain patients that allows the physician to make small adjustments to the implanted lens during several in-office procedures after the initial surgery to improve visual acuity without glasses.”